These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 710027)

  • 1. Protein binding of tolmetin.
    Selley ML; Madsen BW; Thomas J
    Clin Pharmacol Ther; 1978 Dec; 24(6):694-705. PubMed ID: 710027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of pH, calcium and chloride ions on the binding of tolmetin to human serum albumin: circular dichroic, dialysis and fluorometric measurements.
    Matsuyama K; Sen AC; Perrin JH
    J Pharm Pharmacol; 1987 Mar; 39(3):190-5. PubMed ID: 2883283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of uremia and hemodialysis on the plasma protein binding of tolmetin.
    Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
    Pharmacology; 1984; 29(6):312-9. PubMed ID: 6505005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma.
    Ojingwa JC; Spahn-Langguth H; Benet LZ
    J Pharmacokinet Biopharm; 1994 Feb; 22(1):19-40. PubMed ID: 8027947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of tolmetin and salicylic acid to human serum albumin as a function of temperature.
    Behm HL; Flynn GL; Wagner JG
    Biopharm Drug Dispos; 1981; 2(3):235-44. PubMed ID: 7295880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furosemide binding to human albumin and plasma of nephrotic children.
    Prandota J; Pruitt AW
    Clin Pharmacol Ther; 1975 Feb; 17(2):159-65. PubMed ID: 235396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of octanoic acid on the reversible protein binding of ketorolac enantiomers to human serum albumin (HSA): comparative liquid chromatographic studies using a HSA chiral stationary phase.
    Hayball PJ; Holman JW; Nation RL
    J Chromatogr B Biomed Appl; 1994 Dec; 662(1):128-33. PubMed ID: 7894686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometry.
    Ding A; Zia-Amirhosseini P; McDonagh AF; Burlingame AL; Benet LZ
    Drug Metab Dispos; 1995 Mar; 23(3):369-76. PubMed ID: 7628303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption and excretion of tolmetin in arthritic patients.
    Grindel JM; Migdalof BH; Plostnieks J
    Clin Pharmacol Ther; 1979 Jul; 26(1):122-8. PubMed ID: 445955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma protein binding of zomepirac sodium.
    O'Neill PJ
    J Pharm Sci; 1981 Jul; 70(7):818-9. PubMed ID: 7264940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The time course of tolmetin and its metabolites in the plasma of individual rats and mice.
    Migdalof BH; Yorgey KA; Popkave CG
    Drug Metab Dispos; 1976; 4(5):468-73. PubMed ID: 10146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans.
    Brunner F; Zini R; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):134-9. PubMed ID: 6201451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds.
    Albengres E; Urien S; Kusmierek J; Tillement JP
    Eur J Rheumatol Inflamm; 1982; 5(2):87-97. PubMed ID: 6806105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro displacement of phenytoin from protein binding by nonsteroidal antiinflammatory drugs tolmetin, ibuprofen, and naproxen in normal and uremic sera.
    Dasgupta A; Timmerman TG
    Ther Drug Monit; 1996 Feb; 18(1):97-9. PubMed ID: 8848829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro-determination of tolmetin in plasma by electron-capture gas chromatography.
    Ng KT
    J Chromatogr; 1978 Dec; 166(2):527-35. PubMed ID: 748362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between oleic acid and drug competitors influence specific binding of thyroxine in serum.
    Lim CF; Curtis AJ; Barlow JW; Topliss DJ; Stockigt JR
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1106-10. PubMed ID: 1939526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of uremia, hemodialysis, and nonesterified fatty acids on zomepirac plasma protein binding.
    Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
    Clin Pharmacol Ther; 1983 Nov; 34(5):681-8. PubMed ID: 6627828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier-protein-mediated enhancement of fatty-acid binding and internalization in human T-lymphocytes.
    Uriel J; Torres JM; Anel A
    Biochim Biophys Acta; 1994 Feb; 1220(3):231-40. PubMed ID: 7508265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.